Abstract:A deficiency in adenosine production(CD73 KO mice) exacerabates cardiac hypertrophy and heart failure in response to systolic overload(transverse aortic constriction; TAC), but genetic disruption of A1 or A3 receptors does not, suggesting additional non-receptor dependent mechanisms by which adenosine attenuates hypertrophy. Here we investigated the role of adenosine receptors and adenosine metabolism in attenuation of cardiomyocyte hypertrophy at the cellular level. In neonatal cardiomyocytes, 5 μM 2-chloroadenosine(CADO; adenosine deaminase resistant adenosine analogue) or 10 μM Adenosine attenuated phenylephrine induced increases in cell surface area, protein synthesis, and ANF expression. Antagonism of adenosine receptors partially blocked the reduction of ANF expression by CADO, but did not restore cell size or protein synthesis. We hypothesized that adenosine uptake/metabolism may contribute to attenuation of hypertrophy. In support of a role for intracellular adenosine metabolism in regulating hypertrophy, Adenosine Kinase(AK) inhibitors Iodotubercidin(ITU) and ABT-702 completely reversed attenuation of cell size, protein synthesis and expression of ANF by CADO or ADO. RNAi depletion of AK in cardiomyocytes also promoted hypertrophy, ANF expression, and insensitivity to CADO. Examination of phenylephrine induced phospho-signaling pathways revealed that CADO had little effect on AKT Ser473 phosphorylation, but did reduce sustained phosphorylation of Raf Ser338 , mTOR Ser2448 , and p70S6k Thr389 (sites associated with activation). Inhibition of AK completely reversed inhibition of these pathways by CADO. Using dominant negative Raf adenovirus, we found that Raf is necessary for phenylephrine to activate mTOR/p70S6k and hypertrophy. In the presence of constitutively active Raf however, CADO still inhibited mTOR/p70S6k and hypertrophy without reducing phosphorylation of ERK Thr204/Tyr202 or AKT Ser473 . Again, reduction of mTOR/p70S6k signaling by CADO was dependent upon adenosine kinase. Together, these results identify adenosine kinase as an important mediator of adenosine attenuation of cardiomyocyte hypertrophy which acts, in part, through inhibition of RAF signaling to mTOR/p70S6k(mTORC1).

Adenylate kinase AK2 isoform integral in embryo and adult heart homeostasis

Subtle Role for Adenylate Kinase 1 in Maintaining Normal Basal Contractile Function and Metabolism in the Murine Heart

Adenylate Kinase Isoform Network: A Major Hub in Cell Energetics and Metabolic Signaling

Adenylate kinase 1 gene deletion disrupts muscle energetic economy despite metabolic rearrangement

Adenylate Kinase and Metabolic Signaling in Cancer Cells

AKT2 Deficiency Induces Retardation of Myocyte Development Through EndoG-MEF2A Signaling in Mouse Heart

PKN2 deficiency leads both to prenatal 'congenital' cardiomyopathy and defective angiotensin II stress responses

Adenosine Kinase Attenuates Cardiomyocyte Microtubule Stabilization and Protects Against Pressure Overload-Induced Hypertrophy and LV Dysfunction.

Impacts of Mutations on Dynamic Allostery of Adenylate Kinase.

PKM2 regulates metabolic flux and oxidative stress in the murine heart

Adenylate kinase 2 (AK2) promotes cell proliferation in insect development

Adenylate Kinase: A Ubiquitous Enzyme Correlated with Medical Conditions

AKT2 Blocks Nucleus Translocation of Apoptosis-Inducing Factor (AIF) and Endonuclease G (endog) While Promoting Caspase Activation During Cardiac Ischemia.

ATPAF1 deficiency impairs ATP synthase assembly and mitochondrial respiration

Aldehyde Dehydrogenase 2 Deficiency Blunts Compensatory Cardiac Hypertrophy Through Modulating Akt Phosphorylation Early after Transverse Aorta Constriction in Mice.

The Na(+)-K(+)-ATPase alpha2-subunit isoform modulates contractility in the perinatal mouse diaphragm

AK2 Promotes the Migration and Invasion of Lung Adenocarcinoma by Activating TGF-β/Smad Pathway in Vitro and in Vivo

Abstract 21116: Adenosine Kinase Regulation of Cardiomyocyte Hypertrophy

AKT2 Regulates Development and Metabolic Homeostasis Via AMPK-depedent Pathway in Skeletal Muscle

Deletion of protein kinase B2 preserves cardiac function by blocking interleukin-6-mediated injury and restores blood pressure during angiotensin II/high-salt-diet-induced hypertension

Deletion of Akt1 Causes Heart Defects and Abnormal Cardiomyocyte Proliferation